Development and pharmaceutical performance of a novel co-processed excipient of alginic acid and microcrystalline cellulose
first_published_at:Oct. 10, 2020, midnight / date_published:Oct. 10, 2020
Papers
-
10/10/2020 -
by
R. Benabbas,
N.M. Sanchez-Ballester,
B. Bataille,
T. Sharkawi,
I. Soulairol
In this investigation, a co-processed excipient (Cop AA-MCC) was formulated through the combination of alginic acid (AA) and microcrystalline cellulose (MCC101) using a high-shear granulator on a laboratory scale. The …
